Global Oligonucleotide Synthesis Market - Segmented by Application, End-User and Geography - Growth, Trends, and Forecast (2018 - 2023)

  • ID: 4557810
  • Report
  • Region: Global
  • 107 pages
  • Mordor Intelligence
1 of 4

FEATURED COMPANIES

  • Agilent Technologies
  • Atdbio
  • Bioautomation
  • Bio-Synthesis
  • Eurofins Genomics
  • Eurogentec
  • MORE
The oligonucleotide synthesis market is expected to grow, at a CAGR of 10.9% during the forecast period. Oligonucleotide synthesis is the chemical synthesis of fragments of nucleic acids which are shorter than the whole genome with defined a sequence. The technique proves to be useful in current laboratory practice because it provides a rapid and affordable access oligonucleotides of the desired sequence.

Increasing Government Investments and R&D Expenditure in Pharmaceutical and Biotechnology Companies

The rise in R&D spending by government and private entities is one of the factors that can explain the recent up rise in the innovation across all areas of the biotech industry. This includes major advances in biological sciences and pharmaceuticals, and the introduction of more effective drugs and curative and preventive treatments aimed at enhancing the quality of human life. Particularly, a rise in incidence of chronic illnesses due to an increase in aging population will continue to drive advancements in drug aimed at oncology and gene therapy to prevent and treat chronic illnesses. Recent legislative developments such as the 21st Century Cures Act, aimed at streamlining FDA approval processes will add to the speed of development and innovation of novel drugs and biotechnology products that can deliver efficacious drug therapies in the sector. This will help to drive the market with a higher CAGR in the forecasted period.

Price Erosion of Synthesized Oligonucleotides

The cost of DNA sequencing has dropped substantially pre-2010 and has dropped by further between 2010 and 2018. This has been a matter of concern for companies manufacturing oligonucleotides as the price of manufacturing has been more or less remained the same. Whereas the selling prices have been reducing rapidly, this is owing to the cut throat completion in the market among several companies in the market. This affects the profit margin, of the companies manufacturing these products drastically in a negative way. This along with other factors such as increasing use of synthesized oligonucleotides in molecular diagnostics and clinical applications will lead to the slowdown of the growth of the oligonucleotide synthesis market in the forecasted period.

North America to Maintain Lead in the Market

North America is expected to dominate the market followed by Europe. Asia Pacific is expected to grow at the highest CAGR during the forecast period. This can be attributed to factors such as the growing availability of synthesized oligonucleotides, along with an increase in R&D funding and activities in the APAC region. The increasing focus of prominent players on APAC is also supporting market growth in the region. However, price erosion and a lack of regulations for therapeutic oligonucleotides could hinder the growth of this market to a certain extent.

Key Developments in the Market:
  • October 2017 – A conference was held which incorporated dialogue between regulators and industry from Chemistry Manufacturing and Controls (CMC), Nonclinical, Clinical Pharmacology, and Clinical disciplines to address the developmental advances, safety, and challenges in the field of oligonucleotide-based therapeutics.
Major Players: AGILENT TECHNOLOGIES, ATDBIO, BIOAUTOMATION, BIO-SYNTHESIS, EUROFINS GENOMICS, EUROGENTEC, GE HEALTHCARE, GENSCRIPT, INTEGRATED DNA TECHNOLOGIES, LGC BIOSEARCH TECHNOLOGIES, MERCK KGAA, NITTO DENKO AVECIA AND THERMO FISHER SCIENTIFIC amongst others.

Reasons to Purchase the Report
  • Current and future oligonucleotide synthesis market outlook in the developed and emerging markets
  • Analysis of various perspectives of the market with the help of Porter’s five forces analysis
  • The segment that is expected to dominate the market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, market shares, and strategies employed by the major market players
  • 3 months analyst support, along with the Market Estimate sheet (in Excel)
Customization of the Report

This report can be customized to meet your requirements. Please contact us for more information.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Agilent Technologies
  • Atdbio
  • Bioautomation
  • Bio-Synthesis
  • Eurofins Genomics
  • Eurogentec
  • MORE
1. Introduction
1.1 Market Definition

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview
5.1 Current Market Scenario
5.2 Porter's Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Product and Services
5.2.5 Competitive Rivalry Within the Industry

6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Increasing Use of Synthesized Oligonucleotides in Molecular Diagnostics and Clinical Applications
6.1.2 Increasing Government Investments and R&D Expenditure in Pharmaceutical and Biotechnology Companies
6.2 Market Restraints
6.2.1 Price Erosion of Synthesized Oligonucleotides
6.2.2 Lack of a Unified Set of Regulations for Therapeutic Oligonucleotides
6.3 Opportunities
6.4 Key Challenges

7. Market Segmentation
7.1 By Application
7.1.1 Research
7.1.1.1 PCR
7.1.1.2 QPCR
7.1.1.3 Sequencing
7.1.1.4 Gene Synthesis
7.1.1.5 Others
7.1.2 Diagnostics
7.1.3 Therapeutics
7.1.3.1 RNAi
7.1.3.2 Nucleic Acid Aptamers
7.1.3.3 DNA/Antisense Oligonucleotides
7.1.3.4 Immunotherapy Applications
7.2 By End User
7.2.1 Academic Research Institutes
7.2.2 Pharmaceutical and Biotechnology Companies
7.2.3 Diagnostic Laboratories
7.3 By Geography
7.3.1 North America
7.3.1.1 United States
7.3.1.2 Canada
7.3.1.3 Mexico
7.3.2 Europe
7.3.2.1 France
7.3.2.2 Germany
7.3.2.3 United Kingdom
7.3.2.4 Italy
7.3.2.5 Spain
7.3.2.6 Rest of Europe
7.3.3 Asia-Pacific
7.3.3.1 India
7.3.3.2 Australia & New Zealand
7.3.3.3 South Korea
7.3.3.4 Others
7.3.4 Rest of World
7.3.4.1 Saudi Arabia
7.3.4.2 Brazil
7.3.4.3 Others

8. Competitive Landscape
8.1 Mergers & Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches

9. Key Players
9.1 Agilent Technologies
9.2 ATDBio
9.3 Bioautomation
9.4 Bio-Synthesis
9.5 Eurofins Genomics
9.6 Eurogentec
9.7 GE Healthcare
9.8 Genscript
9.9 Integrated DNA Technologies
9.10 LGC Biosearch Technologies
9.11 Merck KGaA
9.12 Nitto Denko Avecia
9.13 Thermo Fisher Scientific
List Not Exhaustive

10. Future of the Market
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Agilent Technologies
  • Atdbio
  • Bioautomation
  • Bio-Synthesis
  • Eurofins Genomics
  • Eurogentec
  • Ge Healthcare
  • Genscript
  • Integrated Dna Technologies
  • Lgc Biosearch Technologies
  • Merck Kgaa
  • Nitto Denko Avecia And Thermo Fisher Scientific.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll